A New Strategy to Reduce Influenza Escape: Detecting Therapeutic Targets Constituted of Invariance Groups

Viruses. 2017 Mar 2;9(3):38. doi: 10.3390/v9030038.

Abstract

The pathogenicity of the different flu species is a real public health problem worldwide. To combat this scourge, we established a method to detect drug targets, reducing the possibility of escape. Besides being able to attach a drug candidate, these targets should have the main characteristic of being part of an essential viral function. The invariance groups that are sets of residues bearing an essential function can be detected genetically. They consist of invariant and synthetic lethal residues (interdependent residues not varying or slightly varying when together). We analyzed an alignment of more than 10,000 hemagglutinin sequences of influenza to detect six invariance groups, close in space, and on the protein surface. In parallel we identified five potential pockets on the surface of hemagglutinin. By combining these results, three potential binding sites were determined that are composed of invariance groups located respectively in the vestigial esterase domain, in the bottom of the stem and in the fusion area. The latter target is constituted of residues involved in the spring-loaded mechanism, an essential step in the fusion process. We propose a model describing how this potential target could block the reorganization of the hemagglutinin HA2 secondary structure and prevent viral entry into the host cell.

Keywords: bioinformatics; drug targets; hemagglutinin; influenza; resistance; synthetic lethality.

MeSH terms

  • Antiviral Agents / isolation & purification*
  • Antiviral Agents / pharmacology
  • Binding Sites
  • Conserved Sequence*
  • Drug Discovery / methods
  • Genes, Essential*
  • Hemagglutinin Glycoproteins, Influenza Virus / chemistry*
  • Hemagglutinin Glycoproteins, Influenza Virus / genetics*
  • Orthomyxoviridae / drug effects*
  • Orthomyxoviridae / physiology*
  • Protein Conformation
  • Virology / methods

Substances

  • Antiviral Agents
  • Hemagglutinin Glycoproteins, Influenza Virus